Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q1 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $1.44 million versus the consensus estimate of $2.32 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.